Across TCGA pan-cancer cohorts, RPL39P40 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RPL39P40 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RPL39P40 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPL39P40 expression acts as an unfavorable survival marker, although some lineages such as STAD and UVM show a favorable association.

STAD, UVM, and UCEC are the cancer types where RPL39P40 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.659	0.427	.004	98	view →
UVM	DFS	Quartile	All	0.768	0.380	.002	53	view →
UCEC	DFS	Median	All	0.923	0.870	.005	52	view →
MESO	OS	Median	II,III,IV	0.402	0.191	.001	50	view →
KIRP	OS	Median	II,III,IV	0.908	0.723	.004	41	view →
CHOL	DFS	Quartile	II,III,IV	0.091	0.699	.010	20	view →
OV	DFS	Quartile	All	0.356	0.443	.031	14	view →
SKCM	OS	Tertile	III,IV	0.607	0.743	.012	13	view →
KICH	DFS	Quartile	III,IV	0.061	0.753	.012	12	view →
LGG	OS	Quartile	All	0.872	0.991	.003	12	view →
LUSC	DFS	Median	All	0.808	0.596	.003	9	view →
BLCA	OS	Median	All	0.751	0.665	.019	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

Exploration

Same gene, other analysis: RPL39P40 tumor-vs-normal RNA expression · all RPL39P40 data types